Top compounds associated with response to GRK3


Feature Type Standardized
Nominal ANOVA
mRNA nelarabine CTRPv2 pan-cancer AAC 0.38 1e-17
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 7e-10
mRNA ML239 CTRPv2 pan-cancer AAC 0.23 2e-08
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.22 8e-08
mRNA decitabine CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 4e-07
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.19 5e-06
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 8e-06
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.16 9e-06
mRNA barasertib CTRPv2 pan-cancer AAC 0.16 2e-05
Download CSV